AGUETTANT NORDIC ApS - CVR: 40873309

2023, EUR

29.08.2024

Bruttoresultat

300'

Primær drift

-310'

Årets resultat

-597'

Aktiver

1.662'

Kortfristede aktiver

1.652'

Egenkapital

-1.175'

Afkastningsgrad

-19 %

Soliditetsgrad

-71 %

Likviditetsgrad

58 %

Resultat

29.08.2024

Årsrapport	2023 29.08.2024	2022 12.06.2023	2021 25.05.2022	2019 31.05.2021
Nettoomsætning
Bruttoresultat	300.487	120.805	887.141	396.157
Resultat af primær drift	-310.117	-590.279	884	-138.885
Indtægter af kapitalandele (tilknyttede og associerede)	0	0	0	0
Finansielle indtægter	23.657	26.792	5.267	2.581
Finansieringsomkostninger	0	-73.121	-31.109	-7.841
Andre finansielle omkostninger	-32.406	0	0	0
Resultat før skat	-419.573	-636.608	-24.958	-144.145
Resultat	-596.564	-496.688	-19.597	-112.435
Forslag til udbytte	0	0	0	0

Aktiver

29.08.2024

Årsrapport	2023 29.08.2024	2022 12.06.2023	2021 25.05.2022	2019 31.05.2021
Kortfristede varebeholdninger	727.476	1.226.046	522.449	341.429
Kortfristede tilgodehavender fra salg og tjenesteydelser	436.947	752.610	949.758	490.440
Likvider	487.954	220.870	434.373	197.085
Kortfristede aktiver	1.652.377	2.199.526	1.906.580	1.028.954
Immaterielle aktiver og goodwill	0	0	0	0
Finansielle anlægsaktiver	9.304	8.969	8.969	8.882
Materielle aktiver	0	0	0	0
Langfristede aktiver	9.304	8.969	8.969	8.882
Aktiver	1.661.681	2.208.495	1.915.549	1.037.836

Aktiver

29.08.2024

Passiver

29.08.2024

Årsrapport	2023 29.08.2024	2022 12.06.2023	2021 25.05.2022	2019 31.05.2021
Forslag til udbytte	0	0	0	0
Egenkapital	-1.175.284	-578.717	-82.031	-62.435
Hensatte forpligtelser	0	0	0	0
Langfristet gæld til banker	0	0	0	0
Anden langfristet gæld			0	0
Leverandører af varer og tjenesteydelser	48.720	283.895	219.028	370.716
Kortfristede forpligtelser	2.836.965	2.787.212	1.997.580	1.100.271
Gældsforpligtelser	2.836.965	2.787.212	1.997.580	1.100.271
Forpligtelser	2.836.965	2.787.212	1.997.580	1.100.271
Passiver	1.661.681	2.208.495	1.915.549	1.037.836

Passiver

29.08.2024

Nøgletal

29.08.2024

Årsrapport	2023 29.08.2024	2022 12.06.2023	2021 25.05.2022	2019 31.05.2021
Afkastningsgrad	-18,7 %	-26,7 %	0,0 %	-13,4 %
Dækningsgrad	Na.	Na.	Na.	Na.
Resultatgrad	Na.	Na.	Na.	Na.
Varelagerets omsætningshastighed	Na.	Na.	Na.	Na.
Egenkapitals-forretning	50,8 %	85,8 %	23,9 %	180,1 %
Payout-ratio	Na.	Na.	Na.	Na.
Gældsdæknings-nøgletal	Na.	-807,3 %	2,8 %	-1.771,3 %
Soliditestgrad	-70,7 %	-26,2 %	-4,3 %	-6,0 %
Likviditetsgrad	58,2 %	78,9 %	95,4 %	93,5 %

Resultat

29.08.2024

Gæld

29.08.2024

Årsrapport

29.08.2024

Nyeste:01.04.2023- 31.03.2024(offentliggjort: 29.08.2024)

Information om virksomhedens regnskabsklasse:The annual report of AGUETTANT NORDIC ApS for 2022/23 has been presented in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B.

Beretning

29.08.2024

Dato for ledelsens godkendelse af årsrapporten:2024-08-27

Ledelsespåtegning: Today, Management has considered and adopted the Annual Report of AGUETTANT NORDIC ApS for the financial year 1 April 2023 - 31 March 2024. The Annual Report is presented in accordance with the Danish Financial Statements Act. In my opinion, the Financial Statements give a true and fair view of the assets, liabilities and financial position of the Company at 31 March 2024 and of the results of the Company's operations for the financial year 1 April 2023 - 31 March 2024. In my opinion, the Management's Review includes a true and fair account of the matters addressed in the review. I recommend that the Annual Report be adopted at the Annual General Meeting. Copenhagen, 27 August 2024 Executive Board Eric Rougemond Director

Statement by Management on the annual report

Identifikation af den godkendte årsrapport:Today, Management has considered and adopted the Annual Report of AGUETTANT NORDIC ApS for the financial year 1 April 2023 - 31 March 2024.

Management's review

Beskrivelse af virksomhedens væsentligste aktiviteter:The Company's principal activities The company's purpose is to conduct business primarily with marketing as well as import, procurement and sales, exports and all other commercial, financial and industrial activities directly or indirectly related to pharmaceuticals, medical devices and cosmetics. Secondary to deal with the purchase, sale, transfer, exchange and management of all types of securities, shares, bonds, government bonds, real estate and chattels. In addition, any kind of investment in existing or future industrial, commercial and financial sectors, real estate or in other liabilities in a sector directly or indirectly related to the company's activities both in Denmark and internationally. Both at your own expense, on behalf of third parties or in collaboration with third parties. The company may generally carry out any financial or industrial operations directly or indirectly related to the company's purposes or which will enable its implementation.